IMPACT BIOMEDICAL INC. - 8-K Filing
Impact Biomedical Inc. announced a 1-for-12.62 reverse stock split effective September 23, 2026 to support its merger with Zoar Limited and compliance with NYSE American listing requirements. (Items: 7.01 Regulation FD Disclosure On September 14, 2026, the Company released a press release relating to its proposed Reverse Stock Split (the “Rever, 9.01 Financial Statements and Exhibits)
Tickers: $IBO